| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| CNCE | CONCERT PHARMACEUTICALS, INC. | Chief Development Officer | Mar 6, 2023 | |||
| TRVI | Trevi Therapeutics, Inc. | Director | Jun 13, 2024 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|